Guangzhou Link Health Pharma Co., Ltd. (Link Health), based in China, and Australian firm George Clinical Pty Ltd (George Clinical) have signed a term sheet to enter into a strategic agreement to establish an independent joint venture clinical development company called Link-George Clinical Research Co., Ltd (Link-George).

Link-George will deliver clinical trials for Link Health and related companies that it has entered into licensing deals with. The plan is for Link-George to launch six clinical trials in 2021 and this is expected to grow as Link Health’s in-licensed portfolio expands.

Link-George will be majority owned by Link Health and operationally led by George Clinical with a board that comprises representatives from both Link Health and George Clinical.

George Clinical is a leading Asia Pacific contract research organization with more than 20 years of experience and a global reach across 38 countries. Collaborating with clients in the areas of biopharmaceuticals, medical devices and diagnostics, it provides a full range of clinical trial services related to all trial phases, registration and post-marketing trials.